Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteomyelitis | 7 | 2023 | 17 | 1.220 |
Why?
|
| Staphylococcal Infections | 3 | 2023 | 64 | 0.540 |
Why?
|
| Musculoskeletal Diseases | 2 | 2020 | 16 | 0.370 |
Why?
|
| Kidney Diseases | 3 | 2006 | 159 | 0.310 |
Why?
|
| Vitamin D Deficiency | 2 | 2005 | 94 | 0.300 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 608 | 0.290 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2018 | 58 | 0.280 |
Why?
|
| Hyponatremia | 1 | 2005 | 6 | 0.260 |
Why?
|
| Hypernatremia | 1 | 2005 | 10 | 0.260 |
Why?
|
| Sodium | 1 | 2005 | 101 | 0.250 |
Why?
|
| Acidosis | 1 | 2004 | 49 | 0.240 |
Why?
|
| Dietary Supplements | 1 | 2005 | 196 | 0.230 |
Why?
|
| Aging | 2 | 2005 | 639 | 0.230 |
Why?
|
| Child, Preschool | 8 | 2019 | 1318 | 0.220 |
Why?
|
| Bacteremia | 1 | 2022 | 31 | 0.210 |
Why?
|
| Orthopedics | 1 | 2020 | 6 | 0.190 |
Why?
|
| Child | 8 | 2022 | 2875 | 0.180 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 19 | 0.180 |
Why?
|
| Workflow | 1 | 2019 | 19 | 0.180 |
Why?
|
| Referral and Consultation | 1 | 2020 | 110 | 0.180 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 27 | 0.170 |
Why?
|
| Weather | 1 | 2018 | 7 | 0.170 |
Why?
|
| Seasons | 1 | 2018 | 112 | 0.160 |
Why?
|
| Acute Disease | 4 | 2022 | 141 | 0.160 |
Why?
|
| Humans | 21 | 2022 | 34853 | 0.150 |
Why?
|
| Retrospective Studies | 5 | 2022 | 1961 | 0.150 |
Why?
|
| Casts, Surgical | 1 | 2016 | 2 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 468 | 0.140 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2016 | 4 | 0.140 |
Why?
|
| Femoral Fractures | 1 | 2016 | 6 | 0.140 |
Why?
|
| Health Surveys | 3 | 2007 | 358 | 0.140 |
Why?
|
| Nutrition Surveys | 3 | 2008 | 228 | 0.140 |
Why?
|
| United States | 8 | 2020 | 3894 | 0.130 |
Why?
|
| Male | 13 | 2020 | 18870 | 0.130 |
Why?
|
| Female | 13 | 2020 | 19873 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2023 | 968 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 2 | 2005 | 137 | 0.120 |
Why?
|
| Aged | 6 | 2008 | 6448 | 0.110 |
Why?
|
| Cardiovascular Diseases | 3 | 2008 | 628 | 0.110 |
Why?
|
| Infant | 4 | 2019 | 1014 | 0.110 |
Why?
|
| Staphylococcus aureus | 2 | 2023 | 80 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2019 | 1353 | 0.100 |
Why?
|
| Adolescent | 6 | 2019 | 5035 | 0.090 |
Why?
|
| Hypertension | 3 | 2007 | 770 | 0.080 |
Why?
|
| Hypertension, Renal | 1 | 2008 | 15 | 0.080 |
Why?
|
| Risk Factors | 4 | 2019 | 3414 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2006 | 469 | 0.080 |
Why?
|
| Texas | 2 | 2019 | 299 | 0.080 |
Why?
|
| Middle Aged | 6 | 2008 | 9642 | 0.080 |
Why?
|
| Prevalence | 4 | 2018 | 1425 | 0.070 |
Why?
|
| Albuminuria | 1 | 2006 | 76 | 0.070 |
Why?
|
| Age Factors | 2 | 2007 | 1007 | 0.070 |
Why?
|
| Education | 1 | 2005 | 48 | 0.070 |
Why?
|
| Benzothiadiazines | 1 | 2005 | 3 | 0.070 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2005 | 8 | 0.070 |
Why?
|
| Vasopressins | 1 | 2005 | 12 | 0.070 |
Why?
|
| Water-Electrolyte Balance | 1 | 2005 | 17 | 0.070 |
Why?
|
| Vitamin D | 1 | 2007 | 176 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 31 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 2 | 2005 | 231 | 0.060 |
Why?
|
| Socioeconomic Factors | 2 | 2006 | 1003 | 0.060 |
Why?
|
| Diuretics | 1 | 2005 | 49 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2004 | 7 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 964 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 56 | 0.060 |
Why?
|
| Mexican Americans | 1 | 2005 | 177 | 0.060 |
Why?
|
| Poverty | 1 | 2006 | 316 | 0.060 |
Why?
|
| Homeostasis | 1 | 2004 | 172 | 0.060 |
Why?
|
| Kidney | 1 | 2005 | 322 | 0.060 |
Why?
|
| Prognosis | 1 | 2005 | 707 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2004 | 202 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2005 | 160 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 207 | 0.050 |
Why?
|
| Adult | 5 | 2008 | 11034 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 600 | 0.050 |
Why?
|
| Clinical Protocols | 1 | 2019 | 34 | 0.050 |
Why?
|
| Contrast Media | 1 | 2019 | 95 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 355 | 0.040 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 30 | 0.040 |
Why?
|
| Registries | 1 | 2019 | 330 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 429 | 0.040 |
Why?
|
| Bone Nails | 1 | 2016 | 5 | 0.040 |
Why?
|
| Comorbidity | 1 | 2018 | 606 | 0.040 |
Why?
|
| Radiography | 1 | 2016 | 75 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 8 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2008 | 195 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1056 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 882 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 167 | 0.030 |
Why?
|
| STAT4 Transcription Factor | 1 | 2014 | 3 | 0.030 |
Why?
|
| Resistin | 1 | 2014 | 3 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1681 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2014 | 14 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 221 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 27 | 0.030 |
Why?
|
| Neutrophils | 1 | 2014 | 124 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2014 | 135 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 147 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 455 | 0.030 |
Why?
|
| Phylogeny | 1 | 2015 | 612 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2016 | 1349 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 638 | 0.030 |
Why?
|
| Algorithms | 2 | 2004 | 435 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4012 | 0.020 |
Why?
|
| Risk | 1 | 2008 | 256 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2007 | 49 | 0.020 |
Why?
|
| Triglycerides | 1 | 2007 | 129 | 0.020 |
Why?
|
| Animals | 1 | 2023 | 14307 | 0.020 |
Why?
|
| Reference Values | 1 | 2006 | 204 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 570 | 0.020 |
Why?
|
| Data Collection | 1 | 2005 | 188 | 0.020 |
Why?
|
| Sex Factors | 1 | 2007 | 859 | 0.020 |
Why?
|
| California | 1 | 2005 | 436 | 0.020 |
Why?
|
| Diabetic Nephropathies | 1 | 2004 | 53 | 0.010 |
Why?
|
| Indians, North American | 1 | 2005 | 145 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 187 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 465 | 0.010 |
Why?
|
| Life Style | 1 | 2004 | 288 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2004 | 284 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 537 | 0.010 |
Why?
|
| Motivation | 1 | 2004 | 415 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 2333 | 0.010 |
Why?
|
| Obesity | 1 | 2007 | 965 | 0.010 |
Why?
|